[Effect of stimulation and blockade of muscarinic receptors on L-arginine-stimulated glucagon secretion in healthy persons and patients with insulin-independent diabetes].
D000328:Adult; D001120:Arginine / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000503:physiopathology*; D004347:Drug Interactions; D005260:Female; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists; D009388:Neostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*; D013268:Stimulation, Chemical
D018727:Muscarinic Antagonists; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D009388:Neostigmine; D001285:Atropine; D005934:Glucagon; D001120:Arginine
Wpływ stymulacji i blokowania receptorów cholinergicznych typu muskarynowego na wydzielanie glukagonu pobudzane L-arginina u ludzi zdrowych i chorych na cukrzyce insulinoniezalezna.